مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro.
Normal view MARC view ISBD view

A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. [electronic resource]

By:
  • Chen, Wen-Liang
Contributor(s):
  • Qian, Yan
  • Meng, Wei-Feng
  • Pang, Ji-Yan
  • Lin, Yong-Cheng
  • Guan, Yong-Yuan
  • Chen, Sheng-Pin
  • Liu, Jie
  • Pei, Zhong
  • Wang, Guan-Lei
Producer: 20091019Description: 941-50 p. digitalISSN:
  • 1873-2968
Subject(s):
  • Cell Survival -- drug effects
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Endothelial Cells -- drug effects
  • Endothelium, Vascular -- drug effects
  • Fluoresceins -- metabolism
  • Fluorescent Dyes -- metabolism
  • Formazans -- analysis
  • Humans
  • Indoles -- metabolism
  • Lipoproteins, LDL -- pharmacology
  • Molecular Structure
  • NADPH Oxidases -- biosynthesis
  • Nitric Oxide -- biosynthesis
  • Oxidation-Reduction
  • Peroxynitrous Acid -- biosynthesis
  • Pyrans -- chemistry
  • Reactive Oxygen Species -- analysis
  • Tetrazolium Salts -- analysis
  • Time Factors
  • Tyrosine -- analogs & derivatives
  • Umbilical Veins -- drug effects
  • Xylariales -- chemistry
Online resources:
  • Available from publisher's website
In: Biochemical pharmacology vol. 78
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 1 Blepharophimosis.
    by FOX, S A
  • 2 Hereditary bilateral ptosis and blepharophimosis associated with other developmental abnormalities of the outer eye.
    by KLEIN, M
  • 3 Blepharophimosis and its operation.
    by NEMETH, L
  • 4 [Komoto syndrome: a case review].
    by Bringué Espuny, X
  • 5 Comments regarding orbitoblepharophimosis syndrome: a 16-year perspective.
    by Seiff, Stuart R
  • 6 A unique and often overlooked cause of Blepharophimosis: "Whistling face syndrome".
    by Kapoor, S
  • 7 Congenital ptosis.
    by Nucci, Paolo
  • 8 [Macular heterotopia with blepharophimosis in two generations].
  • 9 [Blepharophimosis, epicanthus inversus and ptosis syndrome (BPES)].
    by Fukushima, Y
  • 10 Further considerations on the surgical correction of blepharophimosis (epicanthus).
    by SPAETH, E B
  • 11 Premature menopause in association with blepharophimosis, ptosis, and epicanthus inversus.
    by Swanton, A
  • 12 Dystopia punctorum lacrimorum, blepharophimosis and partial atrophy of the iris in a deaf-mute patient.
    by WAARDENBURG, P J
  • 13 [Problems in ocular genetics. IV. Ptosis with congenital hereditary blepharophimosis].
    by GEDDA, L
  • 14 [Blepharophimosis ptosis epicanthus inversus syndrome (BPES) (corrected)].
    by Tyers, A
  • 15 [The syndrome of blepharophimosis-ptosis-dystopia of the inferior puncta lacrimalia and epicanthus].
    by Dumitrache, L
  • 16 [Primary congenital ectropion. Apropos of 2 cases].
    by Morax, S
  • 17 Single-stage surgery for Blepharophimosis syndrome.
    by Bhattacharjee, Kasturi
  • 18 Hereditary blepharophimosis, ptosis, and epicanthus inversus.
    by OWENS, N
  • 19 Modification of Mustardé technique for correction of epicanthus in Asian patients.
    by Patel, B C
  • 20 Operations for epicanthus and blepharophimosis; an evaluation and a method for shortening the medial canthal ligament.
    by JOHNSON, C C
Close

A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro.

APA

Chen W., Qian Y., Meng W., Pang J., Lin Y., Guan Y., Chen S., Liu J., Pei Z. & Wang G. (20091019). A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. : Biochemical pharmacology.

Chicago

Chen Wen-Liang, Qian Yan, Meng Wei-Feng, Pang Ji-Yan, Lin Yong-Cheng, Guan Yong-Yuan, Chen Sheng-Pin, Liu Jie, Pei Zhong and Wang Guan-Lei. 20091019. A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. : Biochemical pharmacology.

Harvard

Chen W., Qian Y., Meng W., Pang J., Lin Y., Guan Y., Chen S., Liu J., Pei Z. and Wang G. (20091019). A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. : Biochemical pharmacology.

MLA

Chen Wen-Liang, Qian Yan, Meng Wei-Feng, Pang Ji-Yan, Lin Yong-Cheng, Guan Yong-Yuan, Chen Sheng-Pin, Liu Jie, Pei Zhong and Wang Guan-Lei. A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. : Biochemical pharmacology. 20091019.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site